Biocryst Pharmaceuticals (BCRX) Short-term Investments: 2010-2014
Historic Short-term Investments for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to $18.2 million.
- Biocryst Pharmaceuticals' Short-term Investments rose 296.52% to $23.7 million in Q3 2015 from the same period last year, while for Sep 2015 it was $23.7 million, marking a year-over-year increase of 296.52%. This contributed to the annual value of $18.2 million for FY2014, which is 7.94% up from last year.
- Latest data reveals that Biocryst Pharmaceuticals reported Short-term Investments of $18.2 million as of FY2014, which was up 7.94% from $16.9 million recorded in FY2013.
- Biocryst Pharmaceuticals' Short-term Investments' 5-year high stood at $40.3 million during FY2010, with a 5-year trough of $14.7 million in FY2012.
- Its 3-year average for Short-term Investments is $16.6 million, with a median of $16.9 million in 2013.
- In the last 5 years, Biocryst Pharmaceuticals' Short-term Investments slumped by 41.81% in 2012 and then climbed by 14.84% in 2013.
- Biocryst Pharmaceuticals' Short-term Investments (Yearly) stood at $40.3 million in 2010, then plummeted by 37.32% to $25.3 million in 2011, then crashed by 41.81% to $14.7 million in 2012, then grew by 14.84% to $16.9 million in 2013, then climbed by 7.94% to $18.2 million in 2014.